Statements (109)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:Clinical_Trials
|
gptkbp:aims_to_determine |
the benefit of chemotherapy
|
gptkbp:aims_to_improve |
unnecessary chemotherapy
|
gptkbp:analyzes |
recurrence scores
|
gptkbp:collaborated_with |
academic institutions
pharmaceutical companies international researchers international research groups |
gptkbp:completed |
gptkb:2015
|
gptkbp:concluded_on |
many women can skip chemotherapy
|
gptkbp:conducted |
multiple countries
multidisciplinary teams clinical settings |
gptkbp:contributes_to |
breast cancer treatment protocols
|
gptkbp:evaluates |
the necessity of chemotherapy
the role of genomic testing |
gptkbp:examines |
gptkb:hormone_receptor-positive_breast_cancer
|
gptkbp:excludes |
HER2-positive patients
|
gptkbp:findings_impact |
treatment guidelines
|
gptkbp:focuses_on |
gptkb:Oncology
|
gptkbp:has_ethical_approval_from |
institutional review boards
|
gptkbp:has_follow_up_studies |
ongoing research projects
|
gptkbp:has_impact_on |
personalized medicine
breast cancer treatment guidelines |
gptkbp:has_implications_for |
personalized treatment plans
|
gptkbp:has_led_to |
new treatment strategies
|
gptkbp:has_long_term_follow_up |
to assess outcomes
|
gptkbp:has_sample_size_of |
over 10,000 women
|
https://www.w3.org/2000/01/rdf-schema#label |
TAILORx Trial
|
gptkbp:includes |
postmenopausal women
|
gptkbp:influences |
patient decision-making
|
gptkbp:involves |
over 10,000 women
women with early-stage breast cancer |
gptkbp:involves_patients_with |
gptkb:hormone_receptor-positive_breast_cancer
|
gptkbp:is_a_guide_for |
clinical decisions
|
gptkbp:is_analyzed_in |
statistical methods
cost-effectiveness systematic reviews adverse effects long-term effects |
gptkbp:is_associated_with |
improved patient outcomes
quality of life assessments improved treatment outcomes. reduced chemotherapy use |
gptkbp:is_cited_in |
numerous research articles
numerous medical publications |
gptkbp:is_collaborative_with |
various cancer research institutions
various cancer centers |
gptkbp:is_considered |
landmark study
|
gptkbp:is_discussed_in |
gptkb:literature
gptkb:healthcare_professionals patient forums |
gptkbp:is_documented_in |
gptkb:guidelines
clinical trial databases clinical trial reports |
gptkbp:is_evaluated_by |
peer review process
treatment efficacy cost-effectiveness peer-reviewed studies quality of life outcomes |
gptkbp:is_funded_by |
gptkb:American_Society_of_Clinical_Oncology
NCI and other organizations |
gptkbp:is_influenced_by |
advancements in genomics
|
gptkbp:is_influential_in |
oncology practices
clinical practice changes shaping treatment protocols |
gptkbp:is_informed_by |
patient feedback
|
gptkbp:is_led_by |
gptkb:Dr._Joseph_A._Sparano
|
gptkbp:is_linked_to |
survival rates
|
gptkbp:is_monitored_by |
gptkb:data_safety_monitoring_board
|
gptkbp:is_part_of |
cancer treatment research
cancer research funding initiatives breast cancer research initiatives larger research initiative evidence-based medicine practices breast cancer research agenda precision medicine approach NCT number NCT00310180 |
gptkbp:is_recognized_by |
medical community
|
gptkbp:is_recognized_for |
its innovative approach
its contribution to oncology |
gptkbp:is_related_to |
precision medicine
breast cancer survival rates |
gptkbp:is_reviewed_by |
regulatory bodies
medical experts |
gptkbp:is_supported_by |
non-profit organizations
pharmaceutical companies government funding patient advocacy groups research grants |
gptkbp:is_utilized_by |
oncologists
|
gptkbp:is_utilized_for |
patient stratification
|
gptkbp:is_utilized_in |
treatment planning
treatment decision-making |
gptkbp:participants |
multiple countries
|
gptkbp:presented_by |
medical conferences
|
gptkbp:provides_information_on |
future research
future breast cancer studies |
gptkbp:published_by |
gptkb:The_New_England_Journal_of_Medicine
clinical trial registries |
gptkbp:published_in |
gptkb:New_England_Journal_of_Medicine
|
gptkbp:reported_by |
gptkb:media_outlets
clinical trial registries medical conferences clinical trial databases |
gptkbp:result |
gptkb:2018
|
gptkbp:sponsored_by |
gptkb:National_Institutes_of_Health
|
gptkbp:started_in |
gptkb:2006
|
gptkbp:uses |
Oncotype DX test
|